EFFECTS OF NALOXONE AND BUPRENORPHINE ON INTRAVENOUS ACETALDEHYDE SELF-INJECTION IN RATS
EFFECTS OF NALOXONE AND BUPRENORPHINE ON INTRAVENOUS ACETALDEHYDE SELF-INJECTION IN RATS
复制标题
DOI:
10.1016/0031-9384(84)90168-9
复制
发表时间:
1984-01-01
影响因子:
2.9
通讯作者:
SINGER, G
中科院分区:
文献类型:
--
作者:
MYERS, WD;NG, KT;SINGER, G
Rats can be induced to self-inject acetaldehyde under an appropriate operant conditioning schedule. The narcotic antagonist naloxone (30 mg/kg) is shown to produce a decrease in schedule-induced acetaldehyde self-injection, but was without effect on both barpress responding and spontaneous activity in rats tested individually for fine, gross and total activity. Buprenorphine (0.3 and 3 mg/kg), the mixed agonist-antagonist derived from the opium alkaloid thebaine, also produced a significant decrease in acetaldehyde self-injection. However, a significant effect of buprenorphine on barpressing in otherwise drug naive rats indicated that this finding should not be dissociated from a possible involvement of buprenorphine on motor responding. While the findings are consistent with the hypothesis of opiate involvement in acetaldehyde self-administration, caution must be exercised when drawing conclusions about the participation of endogenous opiates in acetaldehyde-mediated behavior.